Amplitude Surgical – First Quarter 2019-20

Sales Growth of 6.0% at Constant Exchange Rates - Seite 2

Registration of the Integral Revision prosthesis in Brazil

ANVISA (Agencia Nacional de Vigilancia Sanitaria), the Brazilian regulatory authority for the registration of medical devices, approved on September 9, 2019 the marketing authorization for the Integral Revision hip prosthesis; this new registration allows Amplitude Latam to expand the product offering in Brazil, in association with the Saturn II double mobility acetabulum¹, registered last May.

Next financial press release

H1 2019-20 sales: February 20, 2020, after market.

About Amplitude Surgical
Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player on the global surgical technology market for lower-limb orthopedics. Amplitude Surgical develops and markets high-end products for orthopedic surgery covering the main disorders affecting the hip, knee and extremities, and notably foot and ankle surgery. Amplitude Surgical develops, in close collaboration with surgeons, numerous high value-added innovations in order to best meet the needs of patients, surgeons and healthcare facilities. A leading player in France, Amplitude Surgical is developing abroad through its subsidiaries and a network of exclusive distributors and agents distributing its products in more than 30 countries. Amplitude Surgical operates on the lower-limb market through the intermediary of its Novastep subsidiaries in France and the United States. At June 30, 2019, Amplitude Surgical had a workforce of 436 employees and recorded sales of c.103 million euros.

¹ Cotyloid cavity.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191121005774/en/